Hamzian Nima, Hashemi Maryam, Ghorbani Mahdi, Aledavood Seyed Amir, Ramezani Mohammad, Bahreyni Toosi Mohammad Hossein
Department of Medical Physics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran.
Iran J Pharm Res. 2019 Fall;18(4):1694-1703. doi: 10.22037/ijpr.2019.14050.12131.
This study aimed to modify the biological response of cells to ionizing radiation by combination therapy using radio-sensitizer agent and anticancer drug. Super paramagnetic iron oxide nanoparticles (SPIONs) were prepared and used with gemcitabine (Gem). These two agents were encapsulated simultaneously intopoly (D, L-lactic-co-glycolic acid) (PLGA) to form multifunctional drug delivery system. The physicochemical characteristics of the nanoparticles (NPs) were studied. The dose enhancement ratio (DER) of various treatment groups was calculated and compared using human breast cancer cell line (MCF-7). The DER for PLGA-SPION-Gem was the highest at 1 GyCo (3.18). Cumulative effect from simultaneous use of two radiosensitizer (Gem and SPIONs) was observed. Thus, we have successfully developed PLGA NPs loaded with gemcitabine and SPIONas a radiosensitizersystem which potentially could be used in radiotherapy.
本研究旨在通过使用放射增敏剂和抗癌药物的联合疗法来改变细胞对电离辐射的生物学反应。制备了超顺磁性氧化铁纳米颗粒(SPIONs)并与吉西他滨(Gem)一起使用。这两种药物同时被包裹在聚(D,L-乳酸-共-乙醇酸)(PLGA)中,形成多功能药物递送系统。研究了纳米颗粒(NPs)的物理化学特性。使用人乳腺癌细胞系(MCF-7)计算并比较了各个治疗组的剂量增强比(DER)。PLGA-SPION-Gem在1 GyCo时的DER最高,为3.18。观察到同时使用两种放射增敏剂(Gem和SPIONs)的累积效应。因此,我们成功开发了负载吉西他滨和SPIONs作为放射增敏剂系统的PLGA纳米颗粒,其有可能用于放射治疗。